INCIDENCE OF MOUSE BLADDER TUMORS FOLLOWING IMPLANTATION OF PARAFFIN PELLETS CONTAINING CERTAIN TRYPTOPHAN METABOLITES.

INCIDENCE OF MOUSE BLADDER TUMORS FOLLOWING IMPLANTATION OF PARAFFIN PELLETS CONTAINING CERTAIN TRYPTOPHAN METABOLITES. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

INCIDENCE OF MOUSE BLADDER TUMORS FOLLOWING IMPLANTATION OF PARAFFIN PELLETS CONTAINING CERTAIN TRYPTOPHAN METABOLITES. Abstract Text:

G T BRYAN,R R BROWN,J M PRICE,

INCIDENCE OF MOUSE BLADDER TUMORS FOLLOWING IMPLANTATION OF PARAFFIN PELLETS CONTAINING CERTAIN TRYPTOPHAN METABOLITES. Publishing Authors By Initials

GT BRYAN,RR BROWN,JM PRICE,

For similar heterocyclic compounds: acids, heterocyclic: xanthurenates research abstracts see: heterocyclic compounds: acids, heterocyclic: xanthurenates research

PUBMED ID PMID:

MEDLINE DATE:

INCIDENCE OF MOUSE BLADDER TUMORS FOLLOWING IMPLANTATION OF PARAFFIN PELLETS CONTAINING CERTAIN TRYPTOPHAN METABOLITES. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Cancer research

VOLUME: 24

Page Numbers: 582-5

Journal Abbreviation: Cancer Res.

ISSN: 0008-5472

DAY: 24

MONTH: May

YEAR: 1964

INCIDENCE OF MOUSE BLADDER TUMORS FOLLOWING IMPLANTATION OF PARAFFIN PELLETS CONTAINING CERTAIN TRYPTOPHAN METABOLITES. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 2984705

INCIDENCE OF MOUSE BLADDER TUMORS FOLLOWING IMPLANTATION OF PARAFFIN PELLETS CONTAINING CERTAIN TRYPTOPHAN METABOLITES. Keywords Mesh Terms:

KEYWORDS: Xanthurenates

MESH TERMS:

Chemical & Substance for Abstract: INCIDENCE OF MOUSE BLADDER TUMORS FOLLOWING IMPLANTATION OF PARAFFIN PELLETS CONTAINING CERTAIN TRYPTOPHAN METABOLITES. Information

Substance Name: Paraffin

Registry Number: 8002-74-2

Grant and Affiliation Information for INCIDENCE OF MOUSE BLADDER TUMORS FOLLOWING IMPLANTATION OF PARAFFIN PELLETS CONTAINING CERTAIN TRYPTOPHAN METABOLITES.

AFFILIATION:

Country: UNITED STATES

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Cancer Res

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

INCIDENCE OF MOUSE BLADDER TUMORS FOLLOWING IMPLANTATION OF PARAFFIN PELLETS CONTAINING CERTAIN TRYPTOPHAN METABOLITES Related Publications

• A Novel Tool for Assessing Set-up Uncertainties Applied to Radical Radiotherapy Patients.
• ACCORN - Revitalising Radiotherapy in England.
• Brain activity related to temporal summation of C-fiber evoked pain.
• Cerebrospinal fluid (CSF) leak and pseudomeningocele formation after posterior fossa tumor resection in children: a retrospective analysis.
• Characterization of Salmonella enterica serovar Typhimurium DT104 invasion in an epithelial cell line (IPEC J2) from porcine small intestine.
• Decreased pulsatile LH secretion in heifers superovulated with eCG or FSH.
• Design of ligands for the purification of anti-MUC1 antibodies by peptide epitope affinity chromatography.
• Dissociation reduction in body therapy during sexual abuse recovery.
• Do human parents face a quantity-quality tradeoff?: evidence from a Shuar community.
• Effect of barley and its amylopectin content on ruminal fermentation and nitrogen utilization in lactating dairy cows.
• Evaluation of voxel-based methods for the statistical analysis of PIB PET amyloid imaging studies in Alzheimer's disease.
• Evidence that testosterone and follicular fluid do not interact in the control of FSH secretion in rams.
• Genetic screens for clock mutants in Drosophila.
• Jumping to interpretations: social anxiety disorder and the identification of emotional facial expressions.
• Neurological complications of alcohol usage.
• Oligosaccharide structures studied by hydrogen-deuterium exchange and MALDI-TOF mass spectrometry.
• On the classification of binary shifts of finite commutant index.
• On the classification of binary shifts of minimal commutant index.
• Optimal Planning and Delivery of Radiotherapy for Oesophago-gastric Junction (OGJ) Cancers.
• Prestorage leukoreduction does not increase hemolysis of stored red cell concentrates.
• Production of monoclonal antibodies recognising the peptide core of MUC2 intestinal mucin.
• Racemic progesterone: predicted in silico and produced in the solid state.
• Structure/activity studies of the anti-MUC1 monoclonal antibody C595 and synthetic MUC1 mucin-core-related peptides and glycopeptides.
• Tetrahymena POT1a regulates telomere length and prevents activation of a cell cycle checkpoint.
• The Potential of Molecular Imaging with PET to Improve the Radiotherapy Treatment Process.
• Therapeutic response of multidrug-resistant Plasmodium falciparum and P. vivax to chloroquine and sulfadoxine-pyrimethamine in southern Papua, Indonesia.
• Tissue-specific regulation of ubiquitin (UbC) transcription by glucocorticoids: in vivo and in vitro analyses.
• Transcriptional regulation of the CO2-concentrating mechanism in a euryhaline, coastal marine cyanobacterium, Synechococcus sp. Strain PCC 7002: role of NdhR/CcmR.
• Treatment benefit on cerebrospinal fluid HIV-1 levels in the setting of systemic virological suppression and failure.
• X-ray Volumetric Imaging (XVI) to Redefine Radiotherapy Margins for Locally Advanced Pancreatic Cancer (LAPC).